Topics

FDA Approves Novel Pandemic Influenza Vaccine

14:47 EST 3 Feb 2020 | Medscape

Audenz (Seqirus) is the first and only adjuvanted, cell-based pandemic vaccine to provide active immunization against the influenza A virus H5N1 strain.
FDA Approvals

Original Article: FDA Approves Novel Pandemic Influenza Vaccine

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Novel Pandemic Influenza Vaccine"

Quick Search

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...